Mikhail Blagosklonny
Mikhail Blagosklonny | |
|---|---|
| Education | MD, PhD |
| Alma mater | First Pavlov State Medical University of St. Peterburg |
| Occupation(s) | Professor of Oncology, Roswell Park Cancer Institute; Editor in Chief Aging and Cell Cycle |
| Scientific career | |
| Fields | Anti-Aging Medicine, Cancer |
| Institutions | Roswell Park Cancer Institute |
Mikhail Blagosklonny is a scientist who studies cancer and aging. In 2009, he was appointed Professor of Oncology at the Roswell Park Cancer Institute in New York.[1]
Career
Blagosklonny earned both his M.D. (Medical Doctorate) in internal medicine and his PhD in experimental medicine & cardiology from the Russian medical university the First Pavlov State Medical University of St. Peterburg.[1]
Blagosklonny was appointed Associate Professor of Medicine at New York Medical College, Valhalla, NY in 2002 before taking a position as a Senior Scientist at Ordway Research Institute, Albany, New York. Blagosklonny held this position until 2009 when he was appointed Professor of Oncology at Roswell Park Cancer Institute.[1]
Blogosklonny's research interests include cancer and targeted cancer therapies that protect normal cells from damage, as well as the underlying mechanisms of aging (biogerontology) and anti-aging drugs and.[1]
Editorial Positions
Editor-in-Chief & Co-Founding editor: Aging;[2] which as of 2013 was the second highest ranked journal in the field of aging research [3]
Editor-in-Chief: Cell Cycle.[4]
Editor-in-Chief: Oncotarget[5]
Founding member: 700forscience;[6] a group of commercialization experts helping to create a grassroots support system, for innovative biotechnology projects.[7]
Selected publications
- Blagosklonny MV. Common drugs and treatments for cancer and age-related diseases: revitalizing answers to NCI's provocative questions. Oncotarget. 2012 Dec;3(12):1711-24. PMID 23565531
- Blagosklonny MV. Increasing healthy lifespan by suppressing aging in our lifetime: preliminary proposal. Cell Cycle. 2010 Dec 15;9(24):4788-94. PMID 21150328
- Blagosklonny MV. Revisiting the antagonistic pleiotropy theory of aging: TOR-driven program and quasi-program. Cell Cycle. 2010 Aug 15;9(16):3151-6. PMID 20724817
- Blagosklonny MV. Answering the ultimate question "What is the Proximal Cause of Aging?". Aging 2012 Dec; 4(12):861-77. PMID 23425777
- Blagosklonny MV. Paradoxes of Aging. Cell Cycle 15 December 2007; 6:24, 2997-3003; PMID 18156807
- Kroemer G, et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 2009 Jan;16(1):3-11. PMID 18846107
- Blagosklonny MV, Pardee, Arthur B. The Restriction Point of the Cell Cycle. In Blagosklonny, MV, ed. Cell Cycle Checkpoints and Cancer.. Austin: Landes Bioscience. ISBN 978-1-58706-067-0.
- Kanekal M et al. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature. 1998 Mar 26;392(6674):405-8. PMID 9537326
- Galluzzi L et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 2012 Jan;19(1):107-20. PMID 21760595
- Giannakakou P et al. p53 is associated with cellular microtubules and is transported to the nucleus by dynein. Nat Cell Biol. 2000 Oct;2(10):709-17. PMID 11025661
References
- ^ a b c d Roswell Park Cancer Center Mikhail Blagosklonny profile Page accessed May 16, 2015
- ^ "Aging Editorial Board". Retrieved 12 Aug 2014.
- ^ "SCImago Aging Field Journal ranks". Retrieved May 16, 2015.
- ^ "Cell Cycle Editorial Board". Retrieved May 16, 2015.
- ^ "Oncotarget Editorial Board". Retrieved May 16, 2015.
- ^ "700forscience founder".
- ^ "700 for science about".